Luizza 1.5/30 Tablet
Product Images NDC 70700-314

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Luizza 1.5/30 (NDC 70700-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)
This is a product description for a combination of Norethindrone Acetate and Ethinyl Estradiol. Norethindrone Acetate is a synthetic hormone used in birth control pills, and Ethinyl Estradiol is a form of estrogen. Both compounds are commonly used in oral contraceptives for preventing pregnancy. The molecular weights of Norethindrone Acetate and Ethinyl Estradiol are 340.46 and 296.40, respectively. *
FDA Label Image

Table Ii Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

Table Ii Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)
This text provides data on mortality rates among different groups of users and non-users, classified by smoking habits and age groups. The study referenced for this information is conducted by P.M. Layde and V. Beral. The mortality rates are presented in deaths per 100,000 woman users, with separate categories for ever users and controls grouped by smoking status. The age groups included in the analysis are 15-24, 25-34, 35-44, and 45+.*
FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)
This text provides a comparative analysis of studies investigating the use of combined oral contraceptives (COC) among women. It includes data from various research projects such as the NICHD Women's Care Study, French E3N cohort Study, Shanghai Women’s Health Study, The Nurses’ Health Study I, Oxford Family Planning Study, and others. The studies assess the relationship between COC usage and health outcomes, comparing "Ever COC use" with "Never COC use." The text presents findings in terms of odds ratios (OR), relative risks (RR), and hazard ratios (HR). The effect estimates help to understand the impact of COC use on different populations studied.*
FDA Label Image

Brief Summary Patient Package Insert Figure 1 (Image 04)

Brief Summary Patient Package Insert Figure 1 (Image 04)
FDA Label Image

Brief Summary Patient Package Insert Figure 2 (Image 05)

Brief Summary Patient Package Insert Figure 2 (Image 05)
FDA Label Image

Detailed Patient Package Insert Figure 1 (Image 06)

Detailed Patient Package Insert Figure 1 (Image 06)
This text guides individuals on how to start their birth control pills based on when their period begins. It provides instructions for both Sunday starters and Day-1 starters, detailing how to place the day label strip accordingly. Additionally, it indicates the correct direction to take the pills each week, from left to right.*
FDA Label Image

Detailed Patient Package Insert Figure 2 (Image 07)

Detailed Patient Package Insert Figure 2 (Image 07)
FDA Label Image

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)
This is -scanned information about Luizza™ 1.5/30, which consists of Norethindrone Acetate and Ethinyl Estradiol Tablets. It is a contraceptive intended to prevent pregnancy. The package contains 3 pouches, each with a blister pack of 21 tablets. Please consult the original document for accurate dosage and administration instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.